These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 6207021)

  • 1. Fifty years of Protein Data Bank in the Journal of Biochemistry.
    Kurisu G
    J Biochem; 2022 Jan; 171(1):3-11. PubMed ID: 34865074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsinogen activation as observed in accelerated molecular dynamics simulations.
    Boechi L; Pierce L; Komives EA; McCammon JA
    Protein Sci; 2014 Nov; 23(11):1550-8. PubMed ID: 25131668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.
    Landgraf KE; Santell L; Billeci KL; Quan C; Young JC; Maun HR; Kirchhofer D; Lazarus RA
    J Biol Chem; 2010 Dec; 285(51):40362-72. PubMed ID: 20937841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atlantic cod trypsins: from basic research to practical applications.
    Gudmundsdóttir A; Pálsdóttir HM
    Mar Biotechnol (NY); 2005; 7(2):77-88. PubMed ID: 15759084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.
    McInerney TL; El Ahmar W; Kemp BE; Poumbourios P
    J Virol; 1998 Feb; 72(2):1523-33. PubMed ID: 9445056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues.
    Brinkmann T; Schäfers J; Gürtler L; Kido H; Niwa Y; Katunuma N; Tschesche H
    J Protein Chem; 1997 Aug; 16(6):651-60. PubMed ID: 9263127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computer modeling study of the interaction between tissue factor pathway inhibitor and blood coagulation factor Xa.
    Yoneda T; Komooka H; Umeyama H
    J Protein Chem; 1997 Aug; 16(6):597-605. PubMed ID: 9263122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication.
    Xu J; Mendez E; Caron PR; Lin C; Murcko MA; Collett MS; Rice CM
    J Virol; 1997 Jul; 71(7):5312-22. PubMed ID: 9188600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition.
    Pizzi E; Tramontano A; Tomei L; La Monica N; Failla C; Sardana M; Wood T; De Francesco R
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):888-92. PubMed ID: 8302861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of substrate specificity in the serine proteases.
    Perona JJ; Craik CS
    Protein Sci; 1995 Mar; 4(3):337-60. PubMed ID: 7795518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
    van de Locht A; Lamba D; Bauer M; Huber R; Friedrich T; Kröger B; Höffken W; Bode W
    EMBO J; 1995 Nov; 14(21):5149-57. PubMed ID: 7489704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometries of functional group interactions in enzyme-ligand complexes: guides for receptor modelling.
    Tintelnot M; Andrews P
    J Comput Aided Mol Des; 1989 Mar; 3(1):67-84. PubMed ID: 2715796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.
    Bode W; Mayr I; Baumann U; Huber R; Stone SR; Hofsteenge J
    EMBO J; 1989 Nov; 8(11):3467-75. PubMed ID: 2583108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthesis of Arg15, Glu15, Met15, and Nle15-aprotinin involving enzymatic peptide bond resynthesis.
    Beckmann J; Mehlich A; Schröder W; Wenzel HR; Tschesche H
    J Protein Chem; 1989 Feb; 8(1):101-13. PubMed ID: 2475133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor.
    Bode W; Walter J; Huber R; Wenzel HR; Tschesche H
    Eur J Biochem; 1984 Oct; 144(1):185-90. PubMed ID: 6207021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of bovine trypsinogen at 1.9 A resolution.
    Kossiakoff AA; Chambers JL; Kay LM; Stroud RM
    Biochemistry; 1977 Feb; 16(4):654-64. PubMed ID: 556951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    J Mol Biol; 1987 Apr; 194(4):751-4. PubMed ID: 2443709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen exchange kinetics of bovine pancreatic trypsin inhibitor beta-sheet protons in trypsin-bovine pancreatic trypsin inhibitor, trypsinogen-bovine pancreatic trypsin inhibitor, and trypsinogen-isoleucylvaline-bovine pancreatic trypsin inhibitor.
    Brandt P; Woodward C
    Biochemistry; 1987 Jun; 26(11):3156-67. PubMed ID: 2440473
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.